ArticleScientific reports2025

Telomerase inhibitors TMPyP4 and BIBR 1532 show synergistic antitumor activity in combination with chemotherapeutic drugs.

Aleksandra Romaniuk-Drapała et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.